Data

Publication Review: Amin Study on Impella and IABP

Top Downloads

Abiomed Cardiogenic Shock Protocol


Data

New PROTECT III Data Demonstrates Impella® Reduces MACCE Compared to IABP

Protected PCI

SEE ALL

Cardiogenic Shock

SEE ALL

Newsletter

SUBSCRIBE

Upcoming Events

12.09.19
Spectrum Heart Team Implementation Course
Grand Rapids, MI
Details
01.08.20
Albuquerque ICE Program
Albuquerque, NM
Details
01.25.20
Escalation Therapy: Full Hemodynamic Support - Introducing the Impella 5.5 Featuring Edward Soltesz, MD, MPH
New Orleans, LA
Details

Dr. Jeff Popma Discusses PROTECT III
data with Dr. Seth Bilazarian

Presentations

Jeffrey J. Popma, MD, Presents Data from PROTECT III Study

Watch this breakfast symposium presentation featuring data from the 2-year study of high-risk PCI patients supported with Impella and IABP

Training

Attend The Complete Revascularization Summit

Interventionalist seeking to better understand complex PCI in the modern era

Presentations

Largest FDA Study of High-Risk PCI Patients Shows Improved Outcomes with Impella® Heart Pumps

Jeffrey J. Popma, MD, presents the latest data from the PROTECT series clinical study
#ProtectedPCI

.@SfMannino discusses what it takes to implement a successful cardiogenic shock algorithm based on his experience at WellStar Health Systems: bit.ly/2OK1BLb

From Protected PCI's Twitter

prev · next
#AbiomedImpella

Today in Phoenix Dr. Ed Soltesz of @ClevelandClinic presented two of the first #Impella 5.5 surgical cases ever performed in the U.S. Dr. Soltesz told those in attendance that “we need to be preemptive with support” in surgery for high-risk patients. pic.twitter.com/zOqC2Eyd71

From Abiomed's Twitter

prev · next